SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-22-078386
Filing Date
2022-07-08
Accepted
2022-07-08 16:30:53
Documents
9
Period of Report
2022-08-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2219817-1_pre14a.htm PRE 14A 857379
2 GRAPHIC lg_invivotherape-4clr.jpg GRAPHIC 31918
3 GRAPHIC sg_richardtosellimd-bw.jpg GRAPHIC 10086
4 GRAPHIC tm2219817d1-pc_appena14c.jpg GRAPHIC 1388123
5 GRAPHIC tm2219817d1-pc_appena24c.jpg GRAPHIC 1048828
6 GRAPHIC tm2219817d1-pc_appenb14c.jpg GRAPHIC 1388123
7 GRAPHIC tm2219817d1-pc_appenb24c.jpg GRAPHIC 1048828
8 GRAPHIC tm2219817d1-pc_01proxybw.jpg GRAPHIC 1131140
9 GRAPHIC tm2219817d1-pc_02proxybw.jpg GRAPHIC 1149320
  Complete submission text file 0001104659-22-078386.txt   10762112
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 221074738
SIC: 3841 Surgical & Medical Instruments & Apparatus